- https://jobcopae.com/employer/major-anabolic-steroids-explained-uses-risks-legality/
-
This surpasses the weight loss seen with semaglutide (Wegovy), which showed 14.9% average loss in the pivotal STEP 1 trialover a similar timeframe.
- Joined on
2026-04-01
Block a user